tiprankstipranks
Trending News
More News >
Adicet Bio (DE:1IJA)
FRANKFURT:1IJA
Germany Market

Adicet Bio (1IJA) Income Statement

Compare
0 Followers

Adicet Bio Income Statement

Last quarter (Q3 2025), Adicet Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Adicet Bio's net income was $-26.86M. See Adicet Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 24.99M$ 9.73M$ 17.90M
Gross Profit
$ -6.47M$ 0.00$ 24.99M$ 9.73M$ 17.90M
Operating Expenses
$ 127.61M$ 152.04M$ 97.54M$ 71.16M$ 57.09M
Depreciation and Amortization
$ 6.47M$ 6.10M$ 5.01M$ 1.54M$ 1.95M
EBITDA
$ -110.65M$ -136.53M$ -64.70M$ -60.41M$ -37.41M
Operating Income
$ -127.61M$ -152.04M$ -72.55M$ -61.43M$ -39.19M
Other Income/Expenses
$ 10.49M$ 9.38M$ 2.76M$ -691.00K$ -302.00K
Pretax Income
$ -117.12M$ -142.66M$ -69.79M$ -62.12M$ -39.49M
Net Income
$ -117.12M$ -142.66M$ -69.79M$ -62.00M$ -36.68M
Per Share Metrics
Basic EPS
$ -1.33$ -3.31$ -1.70$ -2.00$ -5.01
Diluted EPS
$ -1.33$ -3.31$ -1.70$ -2.00$ -5.01
Weighted Average Shares Outstanding
87.87M 43.04M 41.08M 30.95M 7.32M
Weighted Average Shares Outstanding (Diluted)
87.87M 43.04M 41.08M 30.95M 7.32M
Currency in USD

Adicet Bio Earnings and Revenue History